Ivana Waller

Optimapharm - CEO of Optimapharm

Profile

With over 20 years of clinical research experience, Ivana Waller has held several executive leadership positions, setting, and executing strategies for global CROs across the USA, Europe, and APAC. Throughout her career, Ivana has developed an extensive global expertise in operational delivery of clinical trials and in leading cross-functional/multicultural teams.
A dynamic leader specialized in operational advancement for contract research organizations, rapid expansions, organic growth, acquisitions, and integrations, Ivana also brings living and working experience in USA, Europe, and APAC to the table.

Ivana Waller is joining Optimapharm from Advance Clinical, where she has served as Senior Vice President of Global Development and Expansion; Managing Director Europe and Asia Pacific since January 2018. She previously spent 8 years in Clinipace Worldwide, serving as Chief Business Officer, Europe and Middle East from January 2016 till December 2017, and Chief Operating Officer from October 2009 to December 2015. Prior to joining Clinipace Worldwide, Ivana acted as Vice President, Business Operations for more than a decade at MedTrials Inc. in USA.

Mrs. Waller holds a BA in Economics at the University of Texas, USA.

Firm Profile
We deliver on your promises
Helping you expedite the development of new medicines, therapies and treatments that advance human health across the globe.

Whether a pharmaceutical, biotech or medical device company, we are your ideal pan-European, full-service CRO.

Our in-depth expertise and long lasting experience combined with a flexible, and collaborative approach allow us to tailor our responses to each individual study.

Our clinical development capabilities span through trial Phases I-IV, across a broad range of therapeutic areas including medical devices.

We have an excellent track record for supporting a range of stakeholders in the pharmaceutical industry including sponsors and research institutions at each clinical development phase.

Our highly experienced team of experts supports a comprehensive network of 26 strategically located offices throughout Europe. This puts a population of more than 500 million people within reach of your study, and we are currently running 250 active trials in 38 different countries.

We believe that the key to a successful, close and collaborative relationship is trust, based on clear and consistent communication. We will listen attentively to your needs and articulate ourselves with straightforward candour and honesty. This provides a robust foundation of shared understanding where everyone’s expectations are met or managed and issues are resolved quickly and openly.

We keep our promises. We possess the experience, knowledge and expertise to make sure we are efficient, dependable, realistic and fair. We are prepared to earn our position as your trusted partner through reliable delivery against agreed project goals. We have the track record, so you can rest assured that your project is in safe hands.

Mission
Leading mid-sized, full-service CRO accross Europe and North America focussed on our People, consistent quality deliver to our Clients, and supporting the development of new therapies to improve and save Patients‘ lives.